Day: November 15, 2019

                                                                                                                                                                                                                                                                                       Company Announcement no. 40 – 2019Copenhagen, November 15th, 2019Change in GreenMobility´s Executive Board to focus on Investor Relations and CSR With effect from 1 January 2020, the Company’s International Director Anders Wall will assume the position of Head of IR and Capital Markets, combined with the management responsibility of CSR, ESG and SDG. Anders Wall has so far been responsible for GreenMobility’s international activities and with 2.5 years of experience in the company has built up a knowledge of the competition in the European carsharing...

TORONTO, Nov. 15, 2019 (GLOBE NEWSWIRE) — Guardian Capital Group Limited (“Guardian”) (TSX:GCG) (TSX:GCG.A) announced today that it intends to purchase by means of a Normal Course Issuer Bid, during the period from November 21, 2019 to November 20, 2020, up to 156,401 or 5% of its outstanding Common Shares, entitled to one vote per share, and up to 1,726,315 or 10% of its Public Float of Class A Non-Voting Shares (“Class A Shares”) as at November 5, 2019. These shares will be purchased at market prices, on the Toronto Stock Exchange and alternative Canadian trading systems.  Guardian intends to purchase the shares for cancellation because it believes that, from time to time, the shares may become undervalued at prevailing market prices, based on Guardian’s earnings and prospects and accordingly, Guardian is of the opinion that the...

CROWN PLACE VCT PLCLEI Code 213800SYIQPA3L3T1Q68                                                                                                                                     TRANSACTION IN OWN SHARES AND TOTAL VOTING RIGHTS AND CAPITALCrown Place VCT PLC (the “Company”) announces that it purchased 155,000 ordinary shares at 32.50 pence per share on 15 November 2019. The shares purchased represent 0.08% of the total number of voting rights in the Company before the transaction.  These shares will be held in treasury.Following this transaction, and in conformity with the provisions of DTR 5.6, we would like to notify the market of the following:The capital of the Company as at 15 November 2019 consisted of 207,170,647 ordinary shares with a nominal value of 1 penny each. The Company holds 21,250,410 ordinary shares in treasury.Therefore,...

KINGS ARMS YARD VCT PLCLEI Code 213800DK8H27QY3J5R45 TRANSACTION IN OWN SHARES AND TOTAL VOTING RIGHTS AND CAPITALKings Arms Yard VCT PLC (the “Company”) announces that it purchased 625,000 ordinary shares at 20.8 pence per share on 15 November 2019. The shares purchased represent 0.19% of the total number of voting rights in the Company before the transaction.  These shares will be held in treasury.Following this transaction, and in conformity with the provisions of DTR 5.6, we would like to notify the market of the following:The capital of the Company as at 15 November 2019 consisted of 388,335,260 ordinary shares with a nominal value of 1 penny each. The Company holds 53,909,000 ordinary shares in treasury.Therefore, the total number of voting rights in the Company is 334,426,260 which may be used by shareholders or other persons as...

ALBION DEVELOPMENT VCT PLCLEI Code 213800FDDMBD9QLHLB38                                                                                                                                     TRANSACTION IN OWN SHARES AND TOTAL VOTING RIGHTS AND CAPITALAlbion Development VCT PLC (the “Company”) announces that it purchased 144,000 ordinary shares at 79.28 pence per share on 15 November 2019. The shares purchased represent 0.17% of the total number of voting rights in the Company before the transaction.  These shares will be held in treasury.Following this transaction, and in conformity with the provisions of DTR 5.6, we would like to notify the market of the following:The capital of the Company as at 15 November 2019 consisted of 93,828,305 ordinary shares with a nominal value of 1 penny each. The Company holds 10,148,156 ordinary shares in...

NEW YORK, Nov. 15, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced a clinical update on omburtamab for Desmoplastic Small Round Cell Tumor (“DSRCT”). Data was presented at the 2019 Connective Tissue Oncology Society (“CTOS”) Annual Meeting in Tokyo, Japan on November 15, 2019, by Dr. Shakeel Modak from Memorial Sloan Kettering Cancer Center (“MSK”) in New York.DSRCT is an aggressive malignancy that typically presents as intraabdominal sarcomatosis in young males. Less than 100 patients are diagnosed each year in the US, and given this incidence, optimal treatment has not yet been defined. Patients with...

ALBION TECHNOLOGY & GENERAL VCT PLCLEI Code 213800TKJUY376H3KN16 TRANSACTION IN OWN SHARES AND TOTAL VOTING RIGHTS AND CAPITALAlbion Technology & General VCT PLC (the “Company”) announces that it purchased 150,000 ordinary shares at 80.8 pence per share on 15 November 2019. The shares purchased represent 0.13% of the total number of voting rights in the Company before the transaction. These shares will be held in treasury.Following this transaction, and in conformity with the provisions of DTR 5.6, we would like to notify the market of the following:The capital of the Company as at 15 November 2019 consisted of 129,232,525 ordinary shares with a nominal value of 1 penny each. The Company holds 17,935,470 ordinary shares in treasury.Therefore, the total number of voting rights in the Company is 111,297,055 which may be used by...

Virbac : availability of the quarterly financial information as of September 30, 2019 Public release – November 15, 2019The quarterly financial information as of September 30, 2019 is available:• on our website: corporate.virbac.com under the section Investors – Financial reports – 2019;• or on request, under legal and regulatory conditions.In accordance with the terms implemented by the French financial markets authority (AMF), this document presents:• significant operations and events of the period;• a description of the group financial standing;• the breakdown of revenue by business segment.Virbac: NYSE Euronext – compartment A – ISIN code: FR0000031577/SYMBOL: VIRPCorporate finance: +33 4 92 08 71 32 – finances@virbac.com – corporate.virbac.comAttachmentVirbac_Quarterly Financial Information_Sept 2019

Virbac : mise à disposition de l’information financière trimestrielle au 30 septembre 2019Communiqué diffusé le 15 novembre 2019L’information financière trimestrielle au 30 septembre 2019 est disponible :• sur notre site internet : corporate.virbac.com dans l’espace Investisseurs – Rapports financiers – 2019 ;• ou sur simple demande, dans les conditions légales et réglementaires.Conformément aux dispositions édictées par l’Autorité des marchés financiers (AMF), ce document présente:• les opérations et évènements significatifs de la période ;• une description de la situation financière et des résultats du groupe ;• la répartition du chiffre d’affaires par secteur d’activité.Virbac : NYSE Euronext – compartiment A – code ISIN : FR0000031577 / MNEMO : VIRPDirection financière : tél. 04 92 08 71 32 – finances@virbac.com...

SANTA CLARA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) — Ambarella, Inc., (NASDAQ: AMBA), a leading developer of low-power and high-resolution human and computer vision solutions, today announced Fermi Wang, CEO, will be presenting at the Deutsche Bank 2019 Auto Tech Conference at the Fairmont Hotel in San Francisco, on Tuesday, December 10, 2019.The “fireside chat” presentation is scheduled for 9:30 AM PST and will be webcast on the Investor events page of Ambarella’s website at http://investor.ambarella.com/events.cfm.  A replay will be available on the website for 90 days.About AmbarellaAmbarella’s products are used in a wide variety of human and computer vision applications, including  video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving, and other robotic...